Nymphaea caerulea

Nymphaea caerulea (Blue Lotus / Blue Water Lily)

1. Identity and Botanical Description

Taxonomy and Nomenclature

Nymphaea caerulea, also known as blue lotus or blue water lily, is a water lily in the genus Nymphaea and is a botanical variety of Nymphaea nouchali. It was first described by Marie Jules César Savigny in 1798 and later classified as a variety of Nymphaea nouchali by Bernard Verdcourt in 1989. Its full accepted scientific name is therefore Nymphaea nouchali var. caerulea (Savigny) Verdc., though it continues to be widely referenced in the scientific literature as Nymphaea caerulea Savigny.

The plant belongs to the family Nymphaeaceae. Common names include Blue Lotus, Egyptian Blue Lily, and Sacred Lily of the Nile. It is not a true lotus; the sacred lotus of Asia is Nelumbo nucifera, and the ancient Egyptians called N. caerulea by the name ššn (seshen).

Morphology and Native Habitat

Nymphaea caerulea is a perennial aquatic herb with a tuberous rhizome which anchors in dam, lake, or river mud, bearing floating rounded leaves 20–40 cm in diameter, with notched margins and a cleft to the centre where a long petiole connects to the rhizome. It is an aquatic plant of freshwater lakes, pools, and rivers, naturally found throughout most of the eastern half of Africa, as well as parts of southern Arabia, but has also been spread to other regions as an ornamental plant. The underwater rhizomes are edible.

Native to the Nile River, the species has become rare due to ecological changes, particularly following the construction of the Aswan Dam, and is now considered threatened.

Plant Parts Used and Common Preparations

The flowers, stems, and roots are used for health-related purposes. The leaf and flower extracts are excellent sources of phytoconstituents when compared with the rhizome and root. Current commercial forms include:

• Dried plant material, teas, and extracts for use in electronic cigarettes.
• Infusions (teas) and tinctures, consumed to induce relaxation and heightened spiritual awareness.
• Flower concrete and absolute (a concentrated aromatic extract), used as a fragrance ingredient in cosmetics.
• Dried plant material, teas, and extracts for electronic cigarettes, available in several forms.

2. Traditional and Historical Use

Ancient Egypt

Ancient Egyptians revered Nymphaea caerulea as a medicinal herb and spiritual flower, a symbol of life and immortality, believing the Blue Lotus could provide a spiritual connection to the Afterlife and communication with the Divine; it served as an essential element in religious ceremonies and shamanic rituals.

There are indications it was grown in special farms over 4,000 years ago to produce enough flowers for votive offerings, although it was apparently also simply grown as an ornamental in traditional Egyptian garden ponds. N. caerulea was considered extremely significant in Egyptian mythology, regarded as a symbol of the sun, since the flowers are closed at night and open again in the morning.

Along with the white lotus, Nymphaea lotus, the plant and flower are very frequently depicted in Ancient Egyptian art, appearing in numerous stone carvings and paintings including the walls of the temple of Karnak, and may be associated with rites pertaining to the afterlife; a number of pharaohs' mummies were covered with the petals of the flower. The body of Tutankhamun — the Egyptian pharaoh who ruled between 1332 and 1323 BCE — was covered with the blueish-white petals of the flower when his tomb was opened in 1922.

The use of N. caerulea and of N. lotos in rites and rituals is depicted in the frescoes within the tombs and in very early papyrus scrolls, the most important of which was the scroll of Ani (Book of the Dead); Nymphaea is mentioned and represented in several chapters of the book, always tied to magical-religious rites.

The flower was notably featured in the Festival of Drunkenness honoring Hathor, goddess of love and fertility, and was believed to induce visions when soaked in wine, possibly used in ecstatic or hallucinogenic rites. Ancient Egyptians utilized Nymphaea caerulea for its calming and euphoric properties, often steeping its petals in wine to prepare a soothing beverage believed to relieve stress, promote relaxation, and enhance mood.

The Ebers Papyrus, dating to circa 1550 BCE, references lotus species in formulations potentially warding off ailments or spirits, though specific recipes blend symbolic and therapeutic intents without isolating N. caerulea exclusively.

A peer-reviewed analysis published in the Journal of the Royal Society of Medicine by Sherratt and colleagues examined the pharmacological plausibility of these ancient uses. They found that the plant produced a variety of reported effects, including enhanced mood and happiness, relaxation, talkativeness, disinhibition, calmness, alertness, heightened awareness, restlessness, tiredness, sedation, drowsiness, and next-day headache; one researcher summarized it as a state of euphoria and tranquilization. Sherratt and colleagues concluded that Nymphaea caerulea might indeed have been used as a drug in ancient Egypt.

Ayurveda and Indian Traditional Medicine

In Ayurvedic medicine, N. caerulea is used for a variety of health-related issues. Nymphaea caerulea Savigny is a multipurpose medicinal plant that has been mentioned for the treatment of liver disorders in Ayurveda, an ancient system of medicine. In Ayurvedic medicine it is used for dyspepsia, enteritis, diarrhea, urinary problems, fevers, and heart palpitations.

The closely related species Nymphaea nouchali (of which N. caerulea is a variety) has extensive documented use in Ayurvedic and Siddha systems. It is an important and well-known medicinal plant in the Ayurveda and Siddha systems of medicine, used for the treatment of diabetes, inflammation, liver disorders, urinary disorders, menorrhagia, blenorrhagia, menstruation problems, as an aphrodisiac, and as a bitter tonic.

Folk Medicine (General)

In folk medicine, the plant is reported to be soothing with tranquilizing effects and is reputedly a detoxicant and aphrodisiac along with astringent and diuretic properties. The plant is reported to be soothing with tranquilizing effects and is reputedly a detoxicant and aphrodisiac along with astringent, diuretic properties.

Mesoamerican Parallels

Similar motifs to those seen in Egyptian art are found in Mayan art, and researchers such as Dobkin de Rios, Diaz, and Emboden hypothesize that Nymphaea plants were used as hallucinogens during religious rites or as "entheogens," symbolic of a union between man and the divine.

3. Phytochemistry: Key Constituents and Active Compounds

Overview

N. caerulea is a rich source of different secondary metabolites such as anthocyanins, anthraquinones, fatty acids, flavonoids, leucoanthocyanins, phenols, coumarins, tannins, and triterpenoids. Research has identified two broad categories of bioactive compounds: aporphine alkaloids and polyphenolic antioxidants.

Aporphine Alkaloids

The notable compounds thought responsible for ritual uses are two aporphine alkaloids: apomorphine and nuciferine. The psychoactive effects of the flower are attributed to these two aporphine alkaloids, which have mixed effects on serotonin and dopamine receptors.

Nuciferine is the principal alkaloid. Nuciferine is an alkaloid found within Nymphaea caerulea and Nelumbo nucifera; it interacts with various serotonin and dopamine receptors, acting as an antagonist of some receptors and as an agonist of others, and additionally acts as a dopamine reuptake inhibitor, among other actions. A 1978 study found that nuciferine acts as a dopamine receptor blocker producing neuroleptic effects, whereas its Hofmann degradation product atherosperminine stimulates dopamine receptors, producing opposing psychopharmacological effects.

Apomorphine is the second key aporphine alkaloid. Apomorphine has been described as a psychoactive alkaloid and is a non-selective dopamine agonist, primarily used in medicine to treat Parkinson's disease as it stimulates dopamine receptors and improves motor function. Apomorphine acts as a non-selective dopamine receptor agonist and serotonin receptor modulator, with partial agonist activity at the serotonin 5-HT1A receptor and antagonist activity at the serotonin 5-HT2A receptor; it is also an α-adrenergic receptor antagonist (alpha blocker).

An important caveat regarding apomorphine's presence in the plant itself: its presence in the plant is doubtful on chemical grounds, and apomorphine might be better classified as a derivative of a natural product rather than a primary constituent. Analytical studies have confirmed inconsistent detection; apomorphine was detected in only two out of five commercial samples analyzed, while nuciferine was detected in all five; the confiscated resin was determined to contain no apomorphine and 4,300 ng/g of nuciferine.

Flavonoids and Polyphenols

A major phytochemical investigation of N. caerulea flowers published in Phytochemistry (Agnihotri et al., 2008) isolated 20 constituents. These included 2S,3S,4S-trihydroxypentanoic acid and myricetin 3-O-(3′′-O-acetyl)-α-L-rhamnoside, along with known compounds including myricetin 3-O-α-L-rhamnoside, myricetin 3-O-β-D-glucoside, quercetin 3-O-(3′′-O-acetyl)-α-L-rhamnoside, quercetin 3-O-α-L-rhamnoside, quercetin 3-O-β-D-glucoside, kaempferol 3-O-(3′′-O-acetyl)-α-L-rhamnoside, kaempferol 3-O-β-D-glucoside, naringenin, β-sitosterol, β-sitosterol palmitate, ethyl gallate, gallic acid, p-coumaric acid, and 4-methoxybenzoic acid.

Two novel acylated anthocyanins have been isolated from the blue flowers of Nymphaea caerulea, identified as delphinidin 3′-O-(2″-O-galloyl-β-galactopyranoside) and delphinidin 3′-O-(2″-O-galloyl-6″-O-acetyl-β-galactopyranoside).

Additional phytochemicals identified in the flower include liensinine, iso-liensinine, neferine, lotusine, pronuciferine, rutin, and hyperin.

Other Secondary Metabolites

More than 150 compounds, including flavonoids, phenolics, alkaloids, and miscellaneous compounds, have been identified from Nymphaea genus extracts, and pure molecules from Nymphaea have exhibited a wide range of pharmacological activities including antimicrobial, anti-inflammatory, anticancer, immunomodulatory, hepatoprotective, antioxidant, and cytotoxic properties.

4. Mechanisms of Action

Dopaminergic System

The plant contains the psychoactive alkaloids nuciferine and apomorphine, which interact with the serotonin, dopamine, and adrenergic systems. Nuciferine's dopaminergic profile is complex: nuciferine is an antagonist at D5 and 5-HT6 receptors, an agonist at 5-HT1A and D4 receptors, and a general dopaminergic compound via the inhibition of the dopamine transporter. Nuciferine has an enriched pharmacological profile, with affinities for a number of serotonergic and dopaminergic receptors, and nuciferine and its derivatives might lead to a new family of atypical antipsychotic compounds.

Serotonergic System

Once in the brain, nuciferine exhibits activity across a wide array of serotonergic subtype receptors (1A, 2A, 2C, 2B, 6, 7) and has been known to interact with dopaminergic receptors by inhibiting dopamine transport. Due to nuciferine's affinity for the serotonin receptors, nuciferine is thought to be the primary molecular agent responsible for inducing the entheogenic-like properties associated with consumption of the blue water lily.

Antioxidant Mechanisms

The EtOAc fraction of N. caerulea flowers was found to be rich with derivatives of food-derived flavonoids such as flavonols, quercetin, kaempferol, and myricetin that have reported antimutagenic and anticarcinogenic properties. Nine of the isolated compounds were considered active antioxidants with IC50 values ranging from 0.34 to 11.0 μg/ml; the most promising activity was found in the EtOAc fraction (IC50 0.2 μg/ml), which can be attributed to the synergistic effect of the compounds present in it.

Anti-inflammatory Mechanisms

Nuciferine has been studied for anti-inflammatory signalling. A recently identified mechanism of action related to its anti-inflammatory properties involves nuciferine inhibiting proinflammatory cytokines via PPARs (peroxisome proliferator-activated receptors) in LPS-induced models, and nuciferine has been shown to alleviate LPS-induced mastitis in mice via suppressing the TLR4-NF-κB signaling pathway.

Adrenergic System

Apomorphine is also an α-adrenergic receptor antagonist (alpha blocker). This property may contribute to vasodilatory and blood pressure–related effects observed at higher doses.

5. Scientific Evidence by Area of Use

It must be noted at the outset that there are currently no completed randomized controlled trials (RCTs) in humans evaluating the therapeutic effects of Nymphaea caerulea extract as a defined intervention. The totality of evidence is classified as preliminary, consisting of in vitro studies, animal models, analytical chemistry, case series (for toxicity), and historical/ethnobotanical documentation.

5.1 Antioxidant Activity

The strongest scientific support for any biological activity of N. caerulea lies in its antioxidant properties, demonstrated in vitro. Antioxidant activities of nine isolated compounds were observed with IC50 values of 1.16, 4.1, 0.75, 1.7, 1.0, 0.34, 11.0, 1.7, and 0.95 μg/ml; the promising activity of the EtOAc fraction (IC50 0.2 μg/ml) could be attributed to the synergistic effect of the compounds present in it. These are in vitro findings only; no human trials have assessed the clinical relevance of these antioxidant effects. Evidence strength: In vitro only; preliminary.

5.2 Anxiolytic and Sedative Effects

In traditional medicine, N. caerulea is reputed to have calming and soothing effects. Nuciferine is an alkaloid associated with dopamine receptor blockade, and today blue lotus flower is used as a sleep aid and anxiety reliever. However, this use is based primarily on traditional reports and the pharmacological activities of its isolated alkaloids rather than controlled clinical trials. No human RCTs studying anxiolytic or hypnotic outcomes from N. caerulea preparations have been published. Evidence strength: Traditional use; receptor pharmacology (in vitro); no human clinical trials.

5.3 Aphrodisiac and Sexual Function

It has been suggested that Nymphaea caerulea was used in ancient Egypt for religious rituals, sexual enhancement, and other purposes, due to the purported presence of nuciferine and apomorphine, the latter of which is also used today to treat erectile dysfunction. Apomorphine's potential use in treating erectile dysfunction may explain the plant's historical reputation as an aphrodisiac. These observations are pharmacological inferences drawn from the known clinical uses of apomorphine as a pharmaceutical drug; there are no clinical studies testing N. caerulea preparations for sexual dysfunction outcomes. Evidence strength: Historical/ethnobotanical; mechanistic inference; no human clinical trials.

5.4 Antimicrobial Activity

The pharmacological effects of the Nymphaea nouchali species group, assessed by in vitro and in vivo experimental methods, include antibacterial properties; a phytochemical study identified nymphal, gallic acid, and quercetin as biologically active, with alkaloids and tannins showing antibacterial activities. In a study specifically on N. caerulea ethanolic flower extracts, crude ethanolic extracts of petals and pollens were tested for antimicrobial activity against E. coli, and both extracts showed similar capability against E. coli ATCC and MDR strains, with MIC values of 0.39 mg/ml and 0.78 mg/ml respectively. These are in vitro findings only, with no clinical relevance established. Evidence strength: In vitro only; preliminary.

5.5 Anticancer / Cytotoxic Activity

In one study exploring the anti-cancer activity of the ethanolic extracts of Nymphaea caerulea flower against the THP-1 monocytic cancer cell line for the first time, the plant was noted to have multiple reported medicinal properties including antioxidant activity, anti-pyretic, anti-viral, anti-inflammatory properties; blue lotus exhibited cytotoxic and apoptotic activities on triple-negative breast cancer cells via ROS generation and p38 MAPK/JNK activation pathway. Initial investigations suggested possible anticancer effects on some cell lines; nevertheless, further study is required. Evidence strength: In vitro cell-line studies only; highly preliminary; no animal or human data.

5.6 Anti-inflammatory Activity

The family Nymphaeaceae has been studied extensively in pharmacognosy due to their ability to produce aminogenic secondary metabolites; these metabolites have been found to have a range of pharmacological activities including analgesic, anti-inflammatory, and antimicrobial properties. Animal model and in vitro data on nuciferine's TLR4-NF-κB and PPAR-mediated anti-inflammatory effects (referenced above) constitute the mechanistic basis for this putative activity. No human clinical trials of N. caerulea for inflammatory conditions have been conducted. Evidence strength: In vitro and animal data only; no human clinical evidence.

5.7 Antidiabetic Activity

Within the broader Nymphaea genus, antidiabetic activity has been documented. Nymphayol, a steroid isolated from the flowers of the closely related Nymphaea nouchali, has been scientifically shown to be responsible for the traditionally claimed antidiabetic activity; it reverses damaged endocrine tissue and stimulates secretion of insulin in β-cells. No equivalent clinical or pharmacological isolation study has been published specifically for N. caerulea and glycaemic control. Evidence strength: Animal/in vitro data on related species; not established for N. caerulea specifically.

5.8 Psychoactive / Entheogenic Effects

Extracts of N. caerulea when ingested or smoked in high doses are reported to produce euphoria and hallucinations. The mechanistic basis of psychoactive effects is attributed to the receptor pharmacology of nuciferine and apomorphine, as described above. The human evidence for psychoactive effects is based on: (a) historical records and archaeological evidence, (b) the known pharmacology of its isolated alkaloids, and (c) clinical case series of adverse events following recreational use (see Safety section). No double-blind, placebo-controlled clinical trial of psychoactive or mood-altering effects has been published. Evidence strength: Historical/ethnobotanical; pharmacological inference; case reports of adverse effects at high doses.

5.9 Antipsychotic Potential

Scientists believe that nuciferine may have potential therapeutic applications as an antipsychotic drug as well as an antidepressant. Furthermore, nuciferine and its derivatives might lead to a new family of atypical antipsychotic compounds. This remains a hypothesis based on receptor binding profile studies; no clinical trials in psychiatric populations have been conducted. Evidence strength: Preliminary hypothesis based on in vitro receptor pharmacology only.

6. Body Systems and Health Areas of Association

• Central Nervous System: Anxiolytic, sedative, mood-enhancing, and potential entheogenic effects via dopaminergic and serotonergic receptor activity.
• Reproductive/Genitourinary System: Historically used as an aphrodisiac; apomorphine's known utility in erectile dysfunction provides mechanistic plausibility.
• Gastrointestinal System: Used in Ayurvedic medicine for dyspepsia, enteritis, and diarrhea.
• Hepatic System: Mentioned for the treatment of liver disorders in Ayurveda.
• Immune/Inflammatory System: Secondary metabolites have been found to have anti-inflammatory and antimicrobial properties.
• Urinary System: Reputedly a diuretic and detoxicant in folk medicine.
• Skin/Cosmetic: Available information does not indicate major safety concerns for the topical application of authentic blue lotus flower concrete or absolute when diluted as a fragrance ingredient.

7. Dosage Forms and Reported Dosages

The Food and Drug Administration (FDA) has not approved the blue lotus flower for consumption in the United States; because of this, there is no generally accepted dosage. Dosages reported in the scientific literature are limited to analytical and toxicological contexts rather than therapeutic studies.

• Tea / Infusion: Blue lotus is consumed as a tea or tincture to induce relaxation and heightened spiritual awareness. No standardized dose has been validated in clinical studies.
• Vaporization (e-cigarette): The confiscated resin analyzed by Poklis et al. (2017) was determined to contain 4,300 ng/g of nuciferine and was shown to aerosolize using a rebuildable dripping atomizer (RDA) electronic cigarette.
• Wine/Alcohol infusion: Historically, flowers were steeped in wine, as documented in Egyptological research; no quantified preparation has been established.
• Cosmetic/Topical: In safety assessment work, topical formulations were evaluated with Nymphaea caerulea flower extract at concentrations including 0.5–1% Nymphaea caerulea flower extract in Balb/c 3T3 fibroblasts, at which dose-dependent cytotoxicity was observed with an IC50 of 14.71 mg/ml, and the test substance was classified as a non-toxic substance.

More research is still needed to better evaluate the benefits and uses of the blue lotus flower.

8. Adulteration and Product Quality

A significant issue in the commercial blue lotus supplement market is the inconsistency and unreliability of product composition. In a 2023 study, six authentic N. caerulea extracts from trusted sources and eleven commercial products were analyzed using gas chromatography–mass spectrometry (GC-MS); the authentic extracts were a mixture of aliphatic hydrocarbons, aromatic alcohols, fatty acids, phenyl derivatives, diterpenoids, phytosterols, and stigmastanes; however, apomorphine and nuciferine, which are responsible for the psychoactive effects of the blue lotus flower, were virtually absent from the authentic blue lotus extracts.

Recent research by UC Berkeley confirmed that the authentic Nymphaea caerulea is chemically distinct from many products sold online, which contain significantly less of the alkaloid nuciferine and are misidentified water lilies. A study found nuciferine in all tested "blue lotus" products, but apomorphine in only a few. These findings underscore that consumers of commercial "blue lotus" products cannot reliably predict the alkaloid content or biological activity of what they are consuming.

9. Safety Considerations and Drug Interactions

Acute Toxicity: Case Series Evidence

The clearest human evidence on N. caerulea's pharmacological effects comes from clinical toxicology. A case series published in Military Medicine (Schimpf et al., 2021) presented five cases of altered mental status that presented to an emergency department after the use of blue lotus (Nymphaea caerulea); the plant extract has been used as a sleep aid and for anxiety relief but is known to cause euphoria and hallucinations at higher doses; providers should be mindful of new psychoactive substance exposures, including those which can be used with electronic cigarettes, as a cause of altered mental status.

Modern recreational use, primarily through drinking infusions or vaping, has been associated with toxicity, causing symptoms like sedation and perceptual disturbances.

Dose-Dependence of Effects

The plant extract has been used as a sleep aid and for anxiety relief but is known to cause euphoria and hallucinations at higher doses. At high doses, blue lotus has psychoactive effects that can cause psychotic symptoms, including hallucinations.

Detection in Standard Drug Screens

Because newer generations of electronic cigarettes can deliver a variety of substances, practitioners need to be mindful of toxicity from a growing number of psychoactives, some of which are not detectable by standard urine drug screens.

Regulatory Status

These products are labeled as natural, but mostly have not been approved by the Federal Drug Administration (FDA) for human consumption. Although it is legal to purchase blue lotus, it is not approved by the regulating authorities for human consumption and may pose some risks.

Specific Populations

Pregnant or breastfeeding women, children, and teenagers should not use it, as proper safety data are lacking.

Drug Interactions

Anyone with liver, kidney, or psychiatric conditions should exercise particular caution, as should those taking medications such as antidepressants, antipsychotics, MAO inhibitors, or blood pressure drugs, due to potential interactions. This concern is mechanistically grounded: apomorphine's activity as a non-selective dopamine agonist and alpha-adrenergic antagonist creates clear pharmacodynamic interaction risks with antihypertensives and dopaminergic drugs. Nuciferine's broad serotonergic and dopaminergic receptor activity creates theoretical risks of interaction with SSRIs, SNRIs, antipsychotics, and MAOIs.

Apomorphine-Specific Toxicology

The significant nausea and vomiting associated with apomorphine in oral and injectable forms is likely the result of its direct effect on the chemoreceptor trigger zone of the area postrema in the floor of the fourth ventricle adjacent to the brainstem. These effects would be expected in individuals consuming high-alkaloid preparations of N. caerulea.

Topical Safety

Available analytical data do not indicate major safety concerns for the topical application of authentic blue lotus flower concrete or absolute when diluted as a fragrance ingredient.

Evidence Gap Summary

Although traditional medicinal usage supports its therapeutic benefits, further preclinical and clinical investigations are necessary to validate its efficacy and safety for pharmaceutical uses. Despite promising historical usage and emerging preclinical evidence, comprehensive clinical validation is still needed to fully substantiate the health benefits attributed to Nymphaea caerulea.

References

• Agnihotri VK et al. (2008). Antioxidant constituents of Nymphaea caerulea flowers. Phytochemistry. PubMed PMID 18534639.
• Dosoky NS et al. (2023). Chemical Composition, Market Survey, and Safety Assessment of Blue Lotus (Nymphaea caerulea Savigny) Extracts. Molecules, 28(20), 7014. PMC10609367.
• Schimpf M, Ulmer T, Hiller H, Barbuto AF. (2021). Toxicity From Blue Lotus (Nymphaea caerulea) After Ingestion or Inhalation: A Case Series. Military Medicine, 188(7-8):e2689–e2692.
• Poklis JL et al. (2017). The Blue Lotus Flower (Nymphea caerulea) Resin Used in a New Type of Electronic Cigarette, the Re-Buildable Dripping Atomizer. Journal of Psychoactive Drugs, 49(3):175–181.
• Bertol E et al. (2004). Nymphaea cults in ancient Egypt and the New World: a lesson in empirical pharmacology. Journal of the Royal Society of Medicine. PMC1079300.
• Wikipedia: Nymphaea nouchali var. caerulea.
• Wikipedia: Nuciferine.
• Systematic review on botanical background, phytochemical and pharmacological properties of Nymphaea nouchali. Journal of Applied Pharmaceutical Research.
• Raja MMM, Sethiya NK, Mishra SH. (2012). A comprehensive review on Nymphaea stellata. PMC3255414.
• The Apoptotic Property of Nymphaea Caerulea Flower Extract on Acute Myeloid Leukaemia Cell Line, THP-1. PMC10911745.
• Keppel Hesselink JM. (2018). Blue Nile Flower Rituals from the Perspective of Transpersonal Psychology — The Role of Nuciferine and its Putative Value as an Antipsychotic Drug. Edelweiss Psychiatry Open Access.
• Selvakumari et al. (2016). Phytochemistry and Pharmacology of the Genus Nymphaea. Journal of Academia and Industrial Research (JAIR).
• Siva Prasad K & Savithramma N. Screening of Phytochemical Constituents of Nymphaea caerulea Savigny.
• Cosmetic Ingredient Review (CIR). Safety Assessment of Nelumbo nucifera-Derived Ingredients (includes Nymphaea caerulea data). 2025.